Pascale Dubray‐Longeras

Improved survival using specialized multidisciplinary board in sarcoma patients

Jean‐Yves Blay, Pauline Soibinet, Nicolas Penel et al. · Annals of Oncology · 2017 · 362 citations · Full text

Medicine, Oncology, Surgery +10

Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database

Sébastien Salas, Noémie Resseguier, Jean‐Yves Blay et al. · Annals of Oncology · 2017 · 172 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact

Jean‐Marc Nabholtz, Catherine Abrial, Marie‐Ange Mouret‐Reynier et al. · Annals of Oncology · 2014 · 122 citations

Medicine, Oncology, Pharmacology +17

OA05.07 IMpower132: PFS and Safety Results with 1L Atezolizumab + Carboplatin/Cisplatin + Pemetrexed in Stage IV Non-Squamous NSCLC

Vassiliki A. Papadimitrakopoulou, Manuel Cobo, Rodolfo Bordoni et al. · Journal of Thoracic Oncology · 2018 · 120 citations · Full text

Medicine, Oncology, Pharmacology +10

Watch and Wait Approach for Re-excision After Unplanned Yet Macroscopically Complete Excision of Extremity and Superficial Truncal Soft Tissue Sarcoma is Safe and Does Not Affect Metastatic Risk or Amputation Rate

Gauthier Decanter, Eberhard Stoeckle, Charles Honoré et al. · Annals of Surgical Oncology · 2019 · 75 citations

Medicine, Oncology, Surgery +11